ProterixBio, Inc will present clinical study results at the European Respiratory Society International Congress, to be held in Milan, Italy, September 9-13th, 2017. The European Respiratory Society (ERS) is the leading professional organization for respiratory medicine in Europe, publishing academic journals and monographs as well as hosting events aimed at educating health professionals. The ERS International Congress is the largest international respiratory meeting in the world.

Brett Masters, Sc.D., chief technology officer of ProterixBio, will give a presentation, titled “Blood biomarker algorithms to guide COPD assessment and risk stratification.” The presentation will highlight the results from a clinical study that enrolled over 400 patients with chronic obstructive pulmonary disease (COPD) and associated blood-based biomarkers with important clinical measures such as shortness of breath (dyspnea) and exacerbation history.